HUYA makes new appointments to executive team

12 March 2015
huya-big

HUYA Bioscience International has appointed Alain Rolland as executive vice president and chief scientific officer.

He has more than 25 years of international leadership experience in biopharma, including positions at Galderma and Valentis. The company has also appointed John Sharp as chief financial officer and Clem Gingras as chief technology officer and chief operating officer for Asia.

Mr Sharp has more than 20 years’ experience in finance, with a biopharma focus. Mr Gingras has 18 years of management and operational experience with international brands.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical